Why are you looking at Srisai Biopharmaceutical Solutions?
Capability
Service linesMEDICAL LABORATORIES
Work mix: 100% prime · 0% sub · primary NAICS 621511 / PSC Q999 MEDICAL- OTHER
Where they win
2 agenciesRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
2 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Srisai Biopharmaceutical Solutions’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $536K in play. Enter a work email for two figures the page cannot show.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Srisai Biopharmaceutical Solutions hold?
Srisai Biopharmaceutical Solutions (UEI DMAXAMHK9XL3) shows $536K across 14 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Srisai Biopharmaceutical Solutions work with?
Srisai Biopharmaceutical Solutions’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (94%), Department of Defense (DOD) (6%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →